A summarised guide to Cell and Gene Therapy

IMU Biosciences has formed a strategic partnership with Eurofins Transplant Genomics, with an exclusive licensing agreement to give the company access to IMU’s proprietary HD Immunology platform for transplant-related clinical development programmes.

What do the six most dangerous hospital superbugs have in common, and what makes each one distinct? MORF-Bio's live webinar compares all six genomes to find out.

Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces that it has been selected to present at a number of leading international conferences this September.

MyAmici and My Green Lab announce collaboration to support more sustainable lab purchasing. The integration helps life-science labs consider environmental impact alongside price and availability with other purchasing solutions to aid sustainability.

LinkGevity’s Dr Carina Kern and Serena Kern-Libera discuss new approach to age-related disease

Partnership provides US-based sequencing and scalable consumer genomics infrastructure, including an at-home DNA collection, to deliver PrecisionLife’s personalized wellness reports to US consumers.